Back

Medscape, LLC

  • Immunotherapy, Adoptive
  • Lupus Erythematosus, Systemic

CAR T Cells in SLE: A New Frontier in Autoimmunity

The goal of this activity is for learners to be better able to understand the potential of CAR T cells to treat B cell-driven SLE, how to identify patients eligible for clinical trials, current evidence for the efficacy of CAR T cells from clinical trials, and the role of the rheumatologist in the patient journey with CAR T-cell therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Faculty 1

All faculty
  • Paolo F Caimi, MD

    Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Feb 9, 2026
  • Last day to claim credit
    Feb 10, 2027 4 months left